Clinical Trial Update: A Study of Anlotinib in Patients With Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Anlotinib in hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN